http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Bender (검색결과 48 건)
- 무료
- 기관 내 무료
- 유료
-
-
-
THIN ADDITIVE BASES FOR MONIC POLYNOMIALS IN F<sub>q</sub>[t]
Bender, Andreas O.,Im, Bo-Hae,Lee, Yoonjin Korean Mathematical Society 2013 대한수학회보 Vol.50 No.2
We explicitly construct a thin basis for the set $\mathbf{M}$ of monic polynomials in one variable $t$ over a finite field ${\mathbb{F}}_q$.
-
-
-
-
Tamas Bender,P. Somogyi,Á. Gógl,E. Sebo†k,Gy Gruber,K. Hodosi,K. Nemes 한국식품영양과학회 2024 Journal of medicinal food Vol.27 No.12
Osteoarthritis is one of the most common locomotor diseases, with a steadily increasing prevalence and incidence. Loxacon® is a food supplement capsule containing vitamins, minerals, and herbal extracts with Boswellia serrata extract andHarpagophytum procumbens extract as its two main active components. The study involved 88 patients at 4 sites. The 88 patientswere divided into 3 groups. The first group received physical therapy and Loxacon® capsules for 5 weeks, while the second group(30 patients) received physical therapy only for 5 weeks, and the third group (30 patients) received physical therapy and placebocapsules for 5 weeks. After 5 weeks, physical therapy was discontinued in all three groups and all groups continued Loxacon®capsules exclusively for an additional 60 days. Physical therapy had been carried out by a standard protocol over 5 weeks. Investigated parameters included Western Ontario and McMaster Universities Arthritis Index (WOMAC) testing, EuropeanQuality of Life (EQ-5D-5L) quality of life test and the Range ofMotion (ROM). Among the 4 visual analogue scale (VAS) valuesinvestigated from WOMAC, significant change was seen for functionality in all three groups; however, the extent of change wastwice as large in the physical therapy + Loxacon® group at Visit 2 in comparison with the other two groups. In the physical therapy+ placebo group, improvement was seen only at the 3rd visit when they were also receiving Loxacon® capsules. The most pronounceddifference was seen in the minimum clinically important difference index, calculated from the quality of life—VAS,where those taking Loxacon® capsules had a chance 3 times as high to obtain clinical improvement versus the other two groups. Our study confirmed that a combination of boswellic acid and harpagosides is beneficial as an additional therapy in knee OA.
-
-
-
Cihan, Yasemin Benderli,Ozturk, Ahmet,Mutlu, Hasan Asian Pacific Journal of Cancer Prevention 2014 Asian Pacific journal of cancer prevention Vol.15 No.5
Background: It has been demonstrated that neutrophil:lymphocyte (NLR) and platelet:lymphocyte (PLR) ratios are associated with prognosis in cancer patients. The aim of this study was to investigate whether pretreatment white blood cell (WBC), neutrophil, lymphocyte, monocyte, platelet, basophil and eosinophil counts, LDH level, NLR and PLR are associated with prognosis in patients with malignant pleural mesothelioma (MPM). Materials and Methods: We retrospectively reviewed files of 50 patients who were managed with a diagnosis of MPM between 2005 and 2010. Demographic and clinical characteristics, treatments, response to treatment and prognostic factors were evaluated, along with relationships between pretreatment blood parameters and prognosis. Results: Overall, 38 men and 12 women were included to the study. Mean age was $61.5{\pm}9.4$ years (range: 39-83 years). There was advanced disease in 86% (n=43) and the histological type was epithelial mesothelioma in the majority (82%). Of the cases, 17 (34%) received radiotherapy, while 42 cases underwent first- and second-line chemotherapy, with cisplatin plus pemetrexed as the most commonly used regimen. In the assessment after therapy, it was found that there was complete response in 4 cases (8%), partial response in 10 cases (20%), stable disease in 17 cases (34%) and progression in 19 cases (38%). Median follow-up was 10 months (range: 10 day-30 months). Median overall survival was found to be 20.7 months while median progression-free survival as 10 months. In univariate and multivariate analyses, it was found that factors significantly affecting overall survival included stage (p=0.030), response to treatment (p=0.026) and monocyte count (p=0.004), while factors affecting disease-free survival included NLR (p=0.018), response to treatment (p=0.001), and PLR score (p=0.003). Conclusions: Overall and disease-free survival was found to be better in cases with a WBC count<8.000, platelet count<300,000, and low NLR and PLR scores in malignant pleural mesothelioma.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
